Company Filing History:
2 out of 5 
2 out of 5,452 
Years Active: 2023-2024
Title: Manisha Singh: A Pioneer in Cancer Immunotherapy
Introduction: Manisha Singh, an innovative inventor based in Houston, TX, has made significant contributions to the field of cancer treatment through her groundbreaking patents. With a total of two patents to her name, her work focuses on enhancing immune function and developing novel methods for treating cancer.
Latest Patents: Among her latest inventions are the following patents:
1. **Methods of CD40 and Toll-like Receptor Immune Activation:** This patent outlines methods and compositions for treating cancer by administering an effective amount of a TLR agonist and a chimeric CD154 polypeptide. The techniques described aim to bolster the immune system's ability to fight cancer effectively.
2. **Methods of CD40 Activation and Immune Checkpoint Blockade:** This invention details methods for cancer treatment that involve administering an immune checkpoint inhibitor along with a chimeric CD154 polypeptide. It focuses on methods to enhance immune function to combat cancerous cells.
Career Highlights: Throughout her career, Manisha Singh has been associated with notable organizations such as Memgen, Inc. and the University of Texas System. Her experience in these institutions has allowed her to advance her research and further contribute to the development of innovative cancer treatments.
Collaborations: Singh has worked alongside esteemed colleagues in her field, including Willem Overwijk and Patrick Hwu. These collaborations have enabled her to combine expertise and push the boundaries of cancer research.
Conclusion: Manisha Singh stands out as an inventor dedicated to the advancement of cancer treatment through her innovative research and patent contributions. Her work exemplifies a commitment to enhancing immune function, promising new possibilities for individuals battling cancer.